A single cardiology visit in the previous year was associated with a 6%-9% absolute reduction in 1-year all-cause mortality across all heart failure severity groups compared to no consultation.
Cohort (n=655,919)
Yes
Does cardiology follow-up reduce 1-year all-cause mortality in patients with heart failure?
A single annual cardiology visit is associated with a significant reduction in 1-year all-cause mortality in heart failure patients, with greater benefits seen with more frequent visits in higher-risk patients.
Effect estimate: 6%-9% absolute reduction
BACKGROUND AND AIMS: Outpatient cardiology follow-up is the cornerstone of heart failure (HF) management, requiring adaptation based on patient severity. However, risk stratification using administrative data is scarce, and the association between follow-up and prognosis according to patient risk has yet to be described at a population level. This study aimed to describe prognosis and management across different strata using simple criteria, including diuretic use and prior HF hospitalization (HFH). METHODS: This nationwide cohort included all French patients reported as having HF in the previous 5 years and alive on 1 January 2020. Patients were categorized into four groups: (i) HFH within the past year (HFH ≤ 1y), (ii) HFH 1-5 years ago (HFH > 1y), (iii) not hospitalized using loop diuretics (NoHFH/LD+), and (iv) not hospitalized without loop diuretics (NoHFH/LD-). Between-group associations, all-cause mortality (ACM), and cardiology follow-up were analysed using survival models. RESULTS: The study included 655 919 patients 80 years (70-87), 48% female. One-year ACM risk was 15.9%, ranging from 8.0% (NoHFH/LD-) to 25.0% (HFH ≤ 1y). Mortality risk was 1.61-fold higher for NoHFH/LD+, 1.83-fold for HFH > 1y, and 2.32-fold for HFH ≤ 1y compared to NoHFH/LD- (P 1y, and 4 visits for HFH ≤ 1y patients. CONCLUSIONS: Despite having a HF diagnosis, 40% of patients do not see a cardiologist annually, regardless of disease severity. Simple stratification based on hospitalization history and diuretic use effectively predicts outcomes. Tailoring the annual number of HF consultations according to this stratification could optimize resource use and reduce avoidable modelled deaths.
Baudry et al. (Sun,) conducted a cohort in Heart failure (n=655,919). Cardiology consultation vs. No consultation was evaluated on 1-year all-cause mortality (6%-9% absolute reduction). A single cardiology visit in the previous year was associated with a 6%-9% absolute reduction in 1-year all-cause mortality across all heart failure severity groups compared to no consultation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: